Telomeres protect chromosomal ends from deterioration and have been shown to be susceptible to shortening by reactive oxygen species (ROS)-induced damage. ROS levels increase during the progression from early to advanced hepatocellular carcinoma (HCC). An independent study found that the telomeres in most HCC tissues lengthened during carcinogenic advancement. Activated telomerase has been hypothesized to elongate telomeres during the progression of malignant HCC, but it remains unclear which signaling pathway is necessary for telomerase activation in HCC. Here, we showed using cell lines derived from human HCC that H 2 O 2 , which is a major component of ROS in living organisms, elongates telomeres by increasing telomerase activity through protein kinase B (AKT) activation. The AKT inhibitor, perifosine, decreased telomere length, cellular viability, and H 2 O 2 -mediated migration and invasion capacity in HCC cells while also inhibiting AKT activation, telomere maintenance, and tumor growth in nude mice. Advanced HCC tissues showed a positive correlation among ROS levels, phosphorylated AKT (pAKT) levels, and telomere length. Furthermore, patients with HCC tumors that have high ROS levels and long telomeres displayed poorer survival rates. These data demonstrate the significant utilities of ROS levels, pAKT levels, and telomere length for predicting a poor prognosis in patients with HCC. Taken together, AKT activation could be essential for telomere maintenance in advanced HCC tumors as well as being an important contributor to malignant HCC progression. Conclusion: We showed that H 2 O 2 contributes to telomere elongation through AKT activation in advanced HCC, suggesting that an AKT inhibitor such as perifosine may be useful for treating patients with malignant HCC. (HEPATOLOGY 2018;67:1378-1391. L iver cancer is the second-leading cause of cancer deaths worldwide,
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iver cancer is the second-leading cause of cancer deaths worldwide, (1) and hepatocellular carcinoma (HCC) accounts for more than 85% of all liver cancers. (2) The major causative factor of HCC is liver cirrhosis (LC). (2) Cirrhosis can be induced by diverse causes, such as infection with hepatitis virus (hepatitis B virus [HBV] and hepatitis C virus [HCV] ), alcohol consumption, and nonalcoholic steatohepatitis, all of which makes it difficult to plan a treatment strategy for patients with HCC based solely on their history of cirrhosis. (2, 3) All of these risk factors contribute to an increase in reactive oxygen species (ROS) levels. ROS levels increase as the grade of HCC increases because of decreased expression of antioxidant enzymes, which are known to decrease more sharply in Grade II and III HCC (advanced HCC) than in Grade I HCC (early HCC). (4) In the absence of telomerase, telomeres shorten as cells divide, eventually leading to cell growth arrest, senescence, and death. (5) (6) (7) (8) Telomerase is essential for telomere elongation and is composed of a catalytic protein subunit (TERT), an RNA component (TR), and several telomerase accessory factors. (5) (6) (7) (8) Oxidative stress, which is mediated by cellular increases in ROS such as H 2 O 2 in vivo, (9) causes telomere shortening. (6, 10, 11) Other studies have shown that from early to advanced HCC, ROS levels are elevated (4, 12) and telomeres are elongated rather than shortened. (13, 14) Increased telomerase activity lengthens telomeres, leading to tumor cell immortalization during human tumor progression. (5, 15) This phenomenon is conserved in liver HCC, where there is a 90%-95% frequency of the HCC showing the telomerase activation-dependent telomere maintenance system. In contrast, the telomerase-independent system, which is also known as the alternative lengthening of telomeres, has been reported to be present at around a 6% frequency in HCC tissues. (2, 8, 16 ) Therefore, we hypothesize that ROS generation increases TERT expression and telomere lengths, thereby promoting the progression of early HCC to advanced HCC.
Recently, perifosine, a protein kinase B (AKT) inhibitor, was shown to decrease telomerase activity and telomere lengths in the lung cancer cell lines, cervical cancer cell lines, and chronic lymphocytic leukemia blood samples. (17) This study suggested that AKT pathway inhibitors such as perifosine could function as potential telomerase inhibitors. (17) Several lines of evidence also suggested that blockade of AKT action inhibits telomerase activity, which could be translated into a promising approach for the treatment of human cancers. (17) (18) (19) Here, we report that H 2 O 2 is a positive regulator of AKT-mediated telomere elongation in liver HCC tumors. Four AKT inhibitors-perifosine, SH-6, MK-2206, and GSK690693-block H 2 O 2 -mediated telomere elongation. We show decreases in telomere length and tumor growth in tumors of nude mice following oral intake of perifosine. Furthermore, our clinical findings demonstrated a significantly positive association between ROS level, phosphor-AKT (pAKT), and telomere length in patients with liver cancer, thereby suggesting that H 2 O 2 generation and AKT activation could be potential therapeutic targets.
Materials and Methods
Standard methods and additional details are described in the Supporting Information.
HUMAN SAMPLES
The Seoul National University Institutional Review Board (SNUIRB No. E1308/001-035) approved this study. For measurement of telomere fluorescence levels and 8-oxo-dG levels, 130 surgically resected paraffinembedded HCC tumor tissue samples and corresponding nontumorous liver tissue samples were analyzed. The cases were prospectively and consecutively identified at Seoul St. Mary's Hospital of the Catholic University of Korea between 2005 and 2009. Based on the immunohistochemistry (IHC) method design for adequate detection of pAKT in paraffin-embedded tissues, we used paraffin-embedded slides from the Inje Biobank of Inje University Busan Paik Hospital. Paraffin-embedded slides from the Seoul St. Mary's Hospital of the Catholic University of Korea were utilized for measurements of telomere length and 8-oxodG levels, survival analysis, and IHC scoring. The histological grade of tumor differentiation was defined according to the Edmondson-Steiner grading system. (20) 
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CELL CULTURE
HCC cells (HepG2, Hep3B, SNU449, and Huh7 cells) were cultured in Dulbecco's modified Eagle's medium (LM001-05; Welgene, Gyeongsan-si, Republic of Korea) supplemented with 10% fetal bovine serum (FBS) (F0600-050; GenDepot, Barker, TX, USA) in a humidified 378C, 5% CO 2 incubator.
(4) THLE-3 was cultured in BEGM (CC-3171 and CC-4175; Lonza, Basel, Switzerland) supplemented with 10% FBS in a 5% CO 2 humidified incubator as recommended by the ATCC manual. H 2 O 2 treatment was performed as described, with some modifications. (4, 12) Additional details are described in the Supporting information.
FLUORESCENCE IN SITU HYBRIDRIZATION
Fluorescent in situ hybridization (FISH) was performed as described. (21) (22) (23) Additional details are described in the Supporting information.
IHC
IHC and IHC scoring systems were performed as previously described (22, 24) or as instructed from the Human Protein Atlas portal (www.proteinatlas.org). Additional details are described in the Supporting information.
TELOMERASE REPEAT AMPLIFICATION PROTOCOL ASSAY
The telomerase repeat amplification protocol was performed using a TRAPEZE RT Telomerase Detection Kit (S7710; Millipore, Darmstadt, Germany) for quantitative determination of telomerase activity according to the manufacturer's instructions.
qRT-PCR
Total RNA was isolated using the RNeasy Mini Kit (cat. # 74104; QIAGEN, Hilden, Germany) according to the manufacturer's protocol. Additional details are described in the Supporting information.
XENOGRAFT ASSAY
The xenograft experimentation was performed in accord with protocols approved by the Seoul National University Institutional Animal Care and Use Committee (Approval number: SNU-160429-6). Additional details are described in the Supporting information.
MIGRATION AND INVASION ASSAY
The migration and invasion assays were performed as described previously. (25) Additional details are described in the Supporting information.
STATISTICAL ANALYSIS
The data in the graphs are expressed as the means and SDs of three independent experiments. Statistical analyses were performed using R software (www. r-project.org) or Prism GraphPad software (version 6.07; GraphPad Software Inc., San Diego, CA). Additional details are described in the Supporting information.
Results

ROS INDUCE TERT UP-REGULATION AND TELOMERE ELONGATION IN HCC CELL LINES
To determine the effect of H 2 O 2 on telomere length, we treated two HCC cell lines, Hep3B and Huh7, with varying concentrations (0-300 lM) of H 2 O 2 . Telomere length, TERT mRNA expression, and TERT protein expression were increased in 300-lM H 2 O 2 -treated HCC cell lines (Fig. 1A,B) . In two other HCC cell lines, SNU-449 and HepG2, telomere length and TERT expression were also increased by 300 lM of H 2 O 2 (Supporting Fig.  S1A ). Concurrent treatment with N-acetylcysteine (NAC), an ROS scavenger, abolished H 2 O 2 -induced TERT expression and extension of the telomeres in each cell line (Fig. 1A,B and Supporting Fig. S1A ). Treatment with paraquat, an ROS generator, also increased telomere length and TERT expression (Supporting Fig. S1B ). These results indicated that ROS can cause the lengthening of telomeres by upregulating TERT expression in HCC cells.
To investigate how H 2 O 2 induces telomere lengthening, RT-PCR was performed to quantify the mRNA expression levels of TERT, hTR, DKC1, NHP2, NOP10, and GAR1, which are the six subunits of telomerase. (26) Only the expression levels for TERT and DKC1 were increased in HCC cells that were treated with 300 lM of H 2 O 2 ( Fig. 1C) . When treated with H 2 O 2 , HCC cells exhibited approximately double the telomerase activity when compared to mock-treated cells, as measured by a telomerase repeat amplification protocol assay (Fig. 1C) . Because TERT and hTR, the catalytic core subunits of telomerase, are sufficient for the reconstitution of telomerase activity in vitro, (24, 27) TERT up-regulation can directly promote telomerase activity. Therefore, we suggest that ROS increase telomerase activity by up-regulating TERT expression at both the mRNA and protein levels in HCC cells.
In contrast to the above results in HCC cells, the telomeres in H 2 O 2 -treated THLE-3 cells, which are immortalized human epithelial cells derived from normal primary liver cells exhibiting characteristics of normal adult liver epithelial cells, were more than 25% shorter (28) (Fig. 1B) . Other nontransformed human cell lines, such as RPE-1 cells and IMR90 cells, also displayed telomere shortening after H 2 O 2 treatment (Supporting Fig. S1C ). Insignificant differences were observed in TERT protein expression and telomerase activity between THLE-3 cells with and without H 2 O 2 treatment (Fig. 1B,C) . This result contrasted with that of H 2 O 2 -treated HCC cells, which displayed a significant difference in TERT protein expression and telomerase activity.
INHIBITORS OF pAKT INHIBIT ROS-MEDIATED TELOMERE ELONGATION AND MIGRATION AND INVASION ENHANCEMENT IN HCC CELL LINES
Next, the effect of AKT inhibitors on telomere length was assessed using three human liver cell lines because we observed that H 2 O 2 exposure induced upregulation of pAKT levels in HCC cells, but no changes to pAKT levels in THLE-3 cells following H 2 O 2 exposure. Perifosine was observed to decrease telomere length in HCC cells, but not in THLE-3 cells ( Fig. 2A,B) . Moreover, telomere length in HCC cells was markedly decreased following cotreatment of perifosine and H 2 O 2 when compared to treatment of perifosine alone (Fig. 2B) . Similar results were observed in cells that were treated with other AKT inhibitors, such as SH-6, MK2206, or GSK 690693 (Supporting Fig. S2 ), indicating that the blockade of AKT activity inhibited H 2 O 2 -mediated telomere elongation in HCC cells.
The difference in the extent of telomere loss and telomere doublets was not significant in HCC cells treated with H 2 O 2 when compared to cells undergoing mock treatment (Fig. 2C,D and Supporting Fig.  S3A ,B). Concurrent treatment with H 2 O 2 and perifosine significantly increased the frequency of telomere loss and telomere doublets in HCC cells (Fig.  2C,D and Supporting Fig. S3A,B) . The frequency of telomere dysfunction-induced foci (TIF), which are used as a marker for telomeric DNA damage, increased in HCC cells treated with H 2 O 2 alone as revealed by the colocalization of phosphorylated H2AX, a DNA damage marker, and telomere FISH ( Fig. 2E and Supporting Fig. S3C ). Generally, it is known that DNA damage to telomeres can induce telomere shortening. (10, 11) Because we observed telomeres lengthening in HCC cells following H 2 O 2 treatment, we suggest that the effect of ROS on telomere lengthening is dominant over damage-induced telomere shortening in HCC cells. Telomere lengths were longer in HCC cells treated with H 2 O 2 than in those with a mock treatment. Furthermore, compared to mock treated cells, telomere lengths were shorter in HCC cells treated with perifosine and H 2 O 2 than in those treated with perifosine alone (Fig. 2B) . To determine whether telomere length influenced HCC malignancy, we compared the migration and invasion capacities in HCC cells treated with either a mock, H 2 O 2 , H 2 O 2 and perifosine, or perifosine alone. Migration and invasion enhancement induced by H 2 O 2 exposure were inhibited by perifosine treatment (Fig. 2F) . Furthermore, migration and invasion capacities were significantly lower in HCC cells treated with perifosine and H 2 O 2 than in those treated with perifosine alone (Fig. 2F) . Overall, this suggests that there is a positive association between telomere length and HCC malignancy.
To examine the effects of perifosine in liver cells harboring varying levels of pAKT expression, we performed proliferation assays using three liver cell lines. These cells included the Huh7 and Hep3B epithelial-type HCC cell lines derived from a patient with early HCC, (29) both of which exhibit high pAKT expression levels, and the THLE-3 cell line, which exhibits low pAKT expression (Fig. 3A) . Perifosine inhibited cell proliferation of both HCC cell lines in a concentration-dependent manner (Supporting Fig. S4) Fig. S4 ). We also evaluated the perifosine-induced inhibition of pAKT and cell proliferation in both HCC cell lines at 20 lM (Fig. 3B ). There were no significant changes in cellular proliferation of THLE-3 cells between treatments with and without perifosine, which was consistent with the observation that the low basal pAKT levels of Overall and recurrence-free survival relative to telomere length and ROS levels. We separated the specimens into two groups based on the median TFI (telomere fluorescence intensity)/CFI (centromere fluorescence intensity) values and 8-oxo-dG intensity as cutoffs, respectively. Abbreviations: DAPI, 4',6-diamidino-2-phenylindole; Median survival (Mo), median survival month; OS, overall survival; RFS, recurrence-free survival. the THLE-3 cells were not decreased by perifosine at 20 lM (Fig. 3B) . Collectively, these results suggest that pAKT is a suitable target for the AKT inhibitormediated decrease in TERT expression and telomere length.
PATIENTS WITH HCC TUMORS THAT HAVE LONGER TELOMERES OR HIGHER ROS LEVELS EXHIBIT HIGHER MORTALITY AND RECURRENCE RATES
Next, we determined whether ROS levels were positively associated with telomere length in human HCC tissue. HCC tissues showing higher 8-oxo-dG levels, which represent higher ROS levels, displayed longer telomere lengths (Fig. 4A and Supporting Fig. S5A ). Linear regression analysis of the data obtained from immunofluorescence in situ hybridization (FISH) assays also revealed a significant positive correlation between ROS levels and telomere lengths (P < 0.0001; Fig. 4B ). We confirmed that similar values were obtained for the telomere lengths in both FISH and qPCR assays in HCC tumors (Supporting Fig.  S5B ). Telomere lengths were increased in early-to advanced-grade HCC tissues (GI to GII and GIII, respectively; Fig. 4C ; Table 1 ), indicating that a long telomere length can act as a prognostic marker for HCC. The 130 surgically treated HCC patients were separated into two groups possessing short and long telomeres, respectively. Among 15 clinical parameters (age, grade, ROS level, AFP level, sex, tumor number, tumor size, pathogen presence, cirrhosis, venous invasion, microvessel invasion, bile duct invasion, serosa invasion, surgical margin invasion, and TERT promoter mutation), the parameters of grade, ROS level, AFP level, venous invasion, serosa invasion, and surgical margin invasion were significantly different between the two groups possessing short and long telomeres. *P < 0.05; **P < 0.01; ***P < 0.001. Abbreviations: a.u., arbitrary units; AFP, alpha-fetoprotein.
Telomere stabilization through increased TERT expression is a gateway to cellular immortalization, which increases the risk of cancer mortality. (5, 7, 8, 30) Here, the telomere length and ROS levels were both positively correlated with HCC mortality and recurrence (log-rank test, P < 0.0001 for telomere lengthrelated overall survival rate [OSR], P < 0.0001 for telomere length-related recurrence-free survival rate [RFSR], P 5 0.0002 for ROS level-related OSR, and P < 0.0001 for ROS level-related RFSR; Fig. 4D ). Multivariate analyses also revealed that telomere length and ROS levels were markedly associated with HCC mortality and recurrence (hazard ratio [HR] 5 5.6533, 95% CI 5 2.13846-14.945, P 5 0.000479 for longer telomere length-related OSR; HR 5 4.2706, 95% CI 5 1.65442-11.024, P 5 0.00270 for longer telomere length-related RFSR; HR 5 2.9311, 95% CI 5 1.19761-7.174, P 5 0.018531 for higher ROS levelrelated OSR; and HR 5 3.4325, 95% CI 5 1.36840-8.610, P 5 0.00858 for higher ROS level-related RFSR; Table 2 ). Overall, our findings suggest that ROS are the essential determinants for increased TERT expression and telomeres in HCC tumors, leading to increased mortality and cancer recurrence.
AKT ACTIVATION IS HIGHLY ASSOCIATED WITH TELOMERE LENGTH MAINTENANCE IN HCC TUMOR CELLS
We next analyzed the association between ROS levels, pAKT, and telomere length in human HCC tissues. In GIII HCC tumor tissues, level of pAKT expression was higher than that in nontumor tissues (Fig. 5A) . Correlations between the pAKT levels and telomere length as well as between the pAKT levels and ROS levels were evaluated using Spearman's rankcorrelation test. High levels of pAKT were strongly associated with not only long telomere length (Spearman's rank correlation coefficient, R 5 0.6632; 95% CI 5 0.2858-0.8625; P 5 0.002: Fig. 5B ), but also high ROS levels (Spearman's rank correlation coefficient, R 5 0.5305; 95% CI 5 0.08622-0.7988; P 5 0.0194: Fig. 5B ) in GIII HCC tumors. This suggests that elevated ROS levels lead to AKT activation through TERT up-regulation, and as a result, telomeres could be lengthened in HCC cells.
To confirm the effectiveness of perifosine in blocking telomere maintenance and tumor growth in vivo, the xenograft assay was performed on nude mice. We found that perifosine suppressed tumor growth in nude mice (Fig. 5C ). pAKT expression levels and telomere fluorescence levels were decreased in tumor derived from mice following oral administration of perifosine compared to tumor derived from mice with vehicle treatment (Fig.  5D ). Taken together, these results showed that perifosine blocked tumor proliferation in vivo by reducing pAKT levels and telomere length.
Discussion
Telomere elongation through telomerase activation enables cells to proliferate immortally and to protect them from genetic instability, thereby allowing cells to progress from a premalignant state to a malignant state. (30, 31) Although other investigators have also reported that telomerase activation is involved in malignant progression of diverse human cancers, the researchers focused on the telomerase function independent of telomere lengthening. For example, telomerase has been reported to regulate nuclear factor kappa B pathway-dependent expression (32, 33) and Wnt/b-catenin pathway targeting gene expression. (34) In this study, we emphasize the importance of the telomere-lengthening function of telomerase in human HCC progression, where most of the malignant HCC tumors exhibited longer telomeres when compared to nontumors, and the ROS levels positively correlated with the telomere length in liver tumor. In addition, patients with HCC that exhibited high ROS levels and long telomeres had poor survival rates. We suggest that the level of pAKT expression is essential for telomere length maintenance during the transition from the premalignant to the malignant tumors. Therefore, HRs are used to describe the effect of each covariate (risk factor). All HRs are relative to the absence of the clinical or molecular event.
Overall and recurrence-free survival analysis in HCC tissues (n 5 130 and 115, respectively). *P < 0.05; **P < 0.01; ***P < 0.001. Abbreviation: AFP, alpha-fetoprotein.
we propose that preventing telomere lengthening by suppressing ROS or pAKT levels can be a therapeutic strategy against malignant liver tumor. TERT promoter mutations are positively correlated with telomerase activation in several cancer tissues. (15) A study in liver showed that TERT expression is high in cirrhotic preneoplastic lesions (the precursors of HCC) possessing TERT promoter mutations compared to those without TERT promoter mutations. (35, 36) The association of TERT promoter mutations with TERT expression or patient survival has been elusive in studies on HCC. TERT promoter mutations may not directly affect TERT expression levels, telomeres, or patient survival rates in HCC tumors, as shown in previous reports (14, 36, 37) and in our current results (Tables 1 and 2 ). This suggests that unlike other cancers, HCC has a mechanistic basis underlying the up-regulation of TERT expression and telomerase activity. In addition to a previous report demonstrating that long telomeres were present in GIII HCC, (13) we found that more than 70% of the GII-GIII HCC tissues displayed longer telomeres than the mean GI HCC telomere length (Supporting Fig. S5C ). Moreover, ROS levels were higher in GII-GIII tissues than in GI tissues (Table 1) . (4) These results indicate that lengthened telomeres and a high level of ROS are characteristics of malignant tumors. Furthermore, we observed that ROS level and telomere length have a significantly positive correlation in HCC tissues and that ROS leads to telomere elongation. Therefore, we conclude that ROS-induced lengthened telomeres result in the transition from premalignant to malignant liver tumor.
Considerable evidence suggests that AKT increases telomerase activity by phosphorylating the TERT protein. (17) (18) (19) Despite this evidence, (17) (18) (19) there is a lack of clinical data and the existence of controversial data, such as a report showing that telomerase activity was not influenced by mutations in all of the putative AKT phosphorylation sites within TERT, (38) which warrants further studies on the casual relationship of AKT and TERT. Our study also revealed that ROS induced telomere lengthening through AKT activation and pAKT inhibitors decreased telomere length and cancer cell proliferation. We showed that telomeres were longer in HCC tissues with HCV when compared to those with other etiological risk factors (such as alcohol and HBV) or unclassified causes (Supporting Fig.  S5D ), suggesting that a strategy for inhibiting AKT activation is more effective in patients with liver cancer and HCV infection. Cellular oxidative stress induces telomere shortening, which adversely affects cell proliferation and survival. (6, 10, 11) In vivo, ROS-induced oxidative stress is destructive to telomeres (9) because telomeric DNA contains highly ROS-sensitive G-rich repeats. (6) In contrast, we showed ROS-induced telomere elongation in this study. This indicates that ROS enhanced telomere elongation by telomerase activation, and telomere elongation surpassed the competitive telomere shortening from oxidative damage, which is thought to occur simultaneously (Fig. 6) . Previous articles reported that telomeres were more severely shortened in HCC tissues compared to cirrhotic tissues and normal liver, and aneuploid tumors showed shorter telomeres than diploid tumors. (22, 39) Accelerated telomere shortening attributed to continual processes of liver destruction and regeneration in response to hepatic injury culminates in LC. Telomere shortening induces a high level of chromosomal instability, thereby leading to liver tumor initiation. (22, 39) Detrimental chromosome instability adversely affects tumor cell viability. (40) We hypothesized that telomere maintenance through H 2 O 2 -mediated AKT activity and telomerase activity is essential in the progression toward advanced HCC (Fig. 6) . In this article, we previously mentioned the possibility that AKT plays a role in TERT protein modification, but AKT appears to be more important in TERT transcription-mediated telomerase activity. Based on our data, TERT mRNA and protein expression markedly increased following a 4-day treatment with H 2 O 2 or paraquat (Fig. 1A,B and Supporting Fig. S1A,B) . A previous report showed a positive association between a high expression of TERT and long telomeres in advanced HCCs. (13) A recent study also showed that the frequency of HCC tumors possessing shorter telomeres, as compared to that of nontumor tissues, was significantly lower in the regional or distant stage than in the localized stage. (41) This suggests that telomere maintenance plays an essential role in the progression of HCC.
A recent study using a yeast model revealed two types of telomerase inactivation: early and late telomerase inactivation (ETI and LTI, respectively). (42) Telomere shortening is elicited by LTI rather than ETI. (42) Telomeres become longer from early to advanced HCC tumors. (13, 14) Based on previous studies, LTI may be evolutionarily conserved during human liver cancer progression. The acquisition of LTI resistance in early HCC tumor cells is thought to be imperative for these cells to develop into the advanced form.
Along with these results, we observed that more than 70% of malignant liver tumor (70.89% in GII HCC; 91.43% in GIII HCC) contains longer telomeres than the mean telomere length of premalignant liver tumor. The present study showed an increase in migration and invasion capacities by ROS and is consistent with our previous study where ROS down-regulated E-cadherin and promoted epithelial-to-mesenchymal transition, which is a representative characteristic of malignant liver tumors. (4) Here, we propose that telomere length maintenance can be suppressed by reducing ROS levels through administration of a proper dose of an antioxidant or by regulation of an antioxidant gene, or by down-regulating pAKT levels during the transition from premalignant to malignant state. As a result, tumor malignancy can be suppressed, thereby improving the survival rate of liver cancer patients.
FIG. 6.
Molecular model illustrating the potential mechanism of telomere length maintenance in malignant liver tumors. We hypothesized that the elevated H 2 O 2 levels in malignant compared to premalignant liver tumors induce an AKT activity-mediated up-regulation of TERT and telomere maintenance or telomere elongation, thereby resulting in an enhanced survival of the malignant tumor cells.
